Additional information
| Trade Name | VINELBINE |
|---|---|
| Generic Name | Vinorelbine |
| Manufacturer | Fresenius Kabi |
| Drug Type | Oncology |
| Indication | Lung cancer |
| Doasage Form | Injectible |
| Packaging | 1 x 5ml /50mg |
VINELBINE (Vinorelbine)-50mg
Vinorelbine is in a class of medications called “vinca alkaloids”. It works by slowing or stopping the growth of cancer cells in your body. It stops the cancer cells from separating into 2 new cells.
It is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, Vinorelbine is indicated in combination with cisplatin.
